NCT00584532View on ClinicalTrials.gov

Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2007

Conditions
Prostate Cancer
Interventions
DRUG

Placebo

10 Placebo Capsules taken orally every day.

DRUG

GCP - Genistein Combined Polysaccharide

Ten 500 mg capsules given orally per day. Total of 5 grams per day per patient.

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT00584532 - Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance. | Biotech Hunter | Biotech Hunter